Press Release

Data supports next regulatory steps for the LIBERTY Robotic System HINGHAM, Mass. , May 05, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic System, the first single-use endovascular robotic system, has received the histopathology report from the

95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studies HINGHAM, Mass. , May 03, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY Robotic system, the first fully disposable

Widely Published Interventional Radiologist Has Earned Well-Regarded Reputation Working with Prestigious Medical Centers in the U.S. and Europe The addition of Professor O’Sullivan, the Clinical Director of Radiology for the Galway Clinic in Ireland ,   E xpands the Company’s EU P resence.

Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal HINGHAM, Mass. , March 16, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.

Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization Objectives HINGHAM, Mass. , March 13, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.

HINGHAM, Mass. , March 09, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic System, the first single-use endovascular robotic system, today announced that an abstract was accepted for a podium presentation at the Israeli Conference on Robotics

Engagement with Interventional Radiologists Reaches Highest Level Yet as Company Continues to Progress Through Regulatory and Clinical Phases; Company Seeking to Create Interest and Anticipation for When the System is Commercialized HINGHAM, Mass. , March 02, 2023 (GLOBE NEWSWIRE) -- Microbot

Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans HINGHAM, Mass. , Feb. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced that Harel

Increases Key Opinion Leaders to 13 Throughout the Americas, Israel, and Europe to Support the Company’s Next Regulatory and Commercialization Paths for the LIBERTY® Robotic System HINGHAM, Mass. , Feb. 27, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.